ATLAS fair value
ATLAS has no fair value for this stock today.
Oriola stock price today, ATLAS forecast and fair value
Healthcare · Pharmaceutical Retailers · Nasdaq Helsinki · Finland
Prices as of Oct 27, 2026 · EUR
ATLAS has no fair value for this stock today.
52%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Oriola a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €0.724 and €0.789; in 9 out of 10, between €0.670 and €0.851. Estimated annual volatility is 25%.
ATLAS does not publish a fair value for ORIOLA.HE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks ORIOLA.HE has traded between €0.726 and €1.26. Today it is 40.2% below that high and 4% above its low.
Its beta is 0.46: it tends to move less than the market.
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products.
Want to see everything about Oriola?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products.
52%: close to a coin flip. In half of the simulated outcomes, ORIOLA.HE ends the month between €0.724 and €0.789.
Oriola's market capitalization is €137M. We do not show a P/E because it has no positive earnings to base one on.
Yes. ORIOLA.HE's current dividend yield is 3.97% at today's price (€0.753).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy